Z
Zenflow
Biotech & Life Sciences · South San Francisco, United States · Founded 2014
Minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate MoreLess
Zenflow is a medical device company that has developed the Spring® System, a minimally invasive treatment for men suffering from an enlarged prostate, also known as benign prostatic hyperplasia (BPH).
The company's approach is to provide a long-term solution that avoids the side effects and risks associated with medications and more invasive surgical procedures. The Spring® System is designed to be a straightforward, office-based procedure that can be completed in a short amount of time, allowing patients to recover quickly and resume their normal activities.
Zenflow is currently in the process of seeking regulatory approval for its device. The company has completed a pivotal clinical trial, the BREEZE study, and is using the results to support its application to the U.S. Food and Drug Administration (FDA) for pre-market approval. To fund this process and prepare for the commercial launch of the Spring® System, Zenflow has recently secured $24 million in a financing round.
Keywords: medical devices, urology, BPH treatment, minimally invasive surgery, healthcare, men's health, medical technology, surgical devices, clinical trials, FDA approval
Company overview
Zenflow company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- South San Francisco, United States
- Employees
- 41
- Open positions
- None listed
- Dealroom signal
- 92.1
Valuation & funding
Zenflow funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Nov 2024 | $24M | $157M | Invus · Cook Medical · F-Prime · MedTech VP | ↗ |
| SERIES BOther financing | Jun 2021 | $24M | $157M | F-Prime · MedTech VP · Astia Angels · Invus | — |
| GRANTOther financing | Feb 2018 | $0 | — | National Institutes of Health · US National Science Foundation | — |
| SERIES AOther financing | Feb 2018 | $31M | $126M | SV Tech Ventures · UpHonest Capital · Invus · MedTech VP | ↗ |
| EARLY VCOther financing | Jan 2017 | $0 | — | Eight Roads Ventures | — |
| SEEDOther financing | Jul 2015 | Y Combinator | — | ||
| SEEDOther financing | Mar 2015 | Wei Guo · Y Combinator | — | ||
| SPINOUTOther financing | Jul 2014 | Stanford University | — |
Growth signals
Zenflow website traffic
Latest recorded traffic for Zenflow is 1.8K monthly website visits, down 66.7% over the last three months. Zenflow's team grew 28.1% over the past year.
Comparisons
Zenflow compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Zenflow's talent
Source: Dealroom Talent Intelligence.
Investors
15 investors on Zenflow's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Zenflow has talent and traffic
team presence
In the news
Latest news about Zenflow
Recent press, funding announcements, and product moves mentioning Zenflow — open to read from the original sources.
Market sentiment
What the market is saying about Zenflow
An AI-synthesized read of the highest-engagement posts about Zenflow on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zenflow’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.